“Epigenetic approaches. Histone deacetylase inhibitors: vorinostat. A new treatment option for advanced cutaneous T-cell lymphoma” (2009) Hematology Meeting Reports (formerly Haematologica Reports), 3(1). doi:10.4081/hmr.v3i1.525.